We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $1.67B
1-Year Est. Return 1.43%
This Fund
S&P 500
This Quarter Est. Return
-6.53%
1 Year Est. Return
-1.43%
3 Year Est. Return
-6.61%
5 Year Est. Return
-27.23%
10 Year Est. Return
AUM
$2.18B
AUM Growth
+$31.1M
Cap. Flow
+$160M
Cap. Flow %
7.34%
Top 10 Hldgs %
25.32%
Holding
187
New
40
Increased
44
Reduced
62
Closed
37

Top Sells

Rank Stock Value
1
EQX icon
Equinox Gold
EQX
+$42.5M
2
ACHC icon
Acadia Healthcare
ACHC
+$38.6M
3
CNXC icon
Concentrix
CNXC
+$36.4M
4
VTRS icon
Viatris
VTRS
+$33.1M
5
MTB icon
M&T Bank
MTB
+$31.3M

Sector Composition

Rank Sector Weight
1 Technology 30.56%
2 Healthcare 19.11%
3 Consumer Discretionary 12.35%
4 Industrials 11.07%
5 Consumer Staples 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPG icon
176
PPG Industries
PPG
$25.4B
-38,710
Closed -$3.97M
RPD icon
177
Rapid7
RPD
$795M
-627,983
Closed -$9.55M
SCL icon
178
Stepan Co
SCL
$1.42B
-183,264
Closed -$8.68M
STT icon
179
State Street
STT
$53.2B
-40,641
Closed -$5.24M
TITN icon
180
Titan Machinery
TITN
$438M
-146,793
Closed -$2.21M
TROX icon
181
Tronox
TROX
$874M
-2,200,423
Closed -$9.18M
UTZ icon
182
Utz Brands
UTZ
$1.26B
-411,457
Closed -$4.27M
VNT icon
183
Vontier
VNT
$4.55B
-35,396
Closed -$1.32M
VSH icon
184
Vishay Intertechnology
VSH
$4.7B
-695,125
Closed -$10.1M
VZ icon
185
Verizon
VZ
$209B
-213,532
Closed -$8.7M
WLY icon
186
John Wiley & Sons Class A
WLY
$2.7B
-28,270
Closed -$866K
ZEUS
187
DELISTED
Olympic Steel
ZEUS
-209,187
Closed -$8.95M

Similar funds

Invenomic Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Invenomic Capital Management held 187 positions worth $2.18B, up 1.4% from $2.15B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Invenomic Capital Management deployed $160M of net new capital in Q1 2026, opening 40 new positions and adding to 44 existing holdings. Its largest new stake was Workday: 559,955 shares worth $72.7M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Acadia Healthcare, an estimated $38.6M trimmed.

  • Invenomic Capital Management's largest Q1 2026 buy was Workday: 559,955 shares worth $72.7M.
  • Invenomic Capital Management added most to Fidelity National Information Services in Q1 2026, an estimated $41.7M increase.
  • Invenomic Capital Management's biggest Q1 2026 reduction was Acadia Healthcare, cutting an estimated $38.6M.
  • Invenomic Capital Management fully exited Equinox Gold in Q1 2026, selling an estimated $42.5M.
  • Invenomic Capital Management's ten largest holdings make up 25% of its $2.18B portfolio in Q1 2026.
  • Invenomic Capital Management opened 40 new positions and closed 37 in Q1 2026.
  • Invenomic Capital Management's portfolio value rose 1.4% quarter-over-quarter to $2.18B.

Based on Invenomic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.